신경자극 : 각종 기술과 세계 시장

Highlights:

The global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028. Whereas the market was $7.7 billion in 2022 (base year).

Spinal cord stimulation devices segment of the global neurostimulation devices market is expected to grow from $2.6 billion in 2023 to $3.2 billion in 2028 at a CAGR of 4.2% for the forecast period of 2023 to 2028.

Hypoglossal nerve stimulation devices segment of the global neurostimulation devices market is expected to grow from $335.5 million in 2023 to $692.1 million in 2028 at a CAGR of 15.6% for the forecast period of 2023 to 2028.

Report Scope:

This report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.

Neurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.

This report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson's disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.

Report Includes:

• 51 tables
• An overview of the global markets and technologies for neurostimulation
• Estimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028
• Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
• Detailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantages
• Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
• Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
• Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
• Comprehensive company profiles of major players of the industry, including Axonics Inc., Boston Scientific Corp., Medtronic PLC, Synapse Biomedical Inc. and Xavant Technology

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing the Study
• What's New in This Update?
• Scope of Report
• Methodology and Information Sources
• Regional Breakdown

Chapter 2 Summary and Highlights

• Market Outlook

Chapter 3 Market and Technology Background

• Overview of Neurostimulation
• Types of Neurostimulation Technologies
• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation (SNS)
• Vagus Nerve Stimulation
• Hypoglossal Nerve Stimulation
• Transcutaneous Electrical Nerve Stimulation
• Transcranial Magnetic Stimulation (TMS)
• Other Neurostimulation Technologies
• Therapeutic Applications for Neurostimulation
• Chronic Pain Management
• Neurological Disorders
• Urinary and Fecal Incontinence
• Obstructive Sleep Apnea
• Chronic Migraine and Headache
• Cardiovascular Diseases
• Gastrointestinal Disorders
• Obesity
• Psychiatric Disorders
• Technological Developments
• MRI Compatibility
• Rechargeable and Non-rechargeable Devices

Chapter 4 Market Dynamics

• Market Trends
• Drivers
• Market Restraints

Chapter 5 Market Breakdown by Technology/Device Type

• Global Market for Neurostimulation Devices by Type
• Spinal Cord Stimulation (SCS) Devices
• Transcutaneous Electrical Nerve Stimulation (TENS) Devices
• Deep Brain Stimulation (DBS) Devices
• Sacral Nerve Stimulation (SNS) Devices
• Vagus Nerve Stimulation (VNS) Devices
• Hypoglossal Nerve Stimulation (HGNS) Devices
• Market Size and Forecast
• Transcranial Magnetic Stimulation (TMS) Devices
• Other Types of Neurostimulation Devices

Chapter 6 Market Breakdown by Therapeutic Application

• Global Market for Neurostimulation Devices by Therapeutic Application
• Chronic Pain
• Urinary and Fecal Incontinence
• Parkinson's Disease
• Epilepsy
• Obstructive Sleep Apnea (OSA)
• Essential Tremor
• Major Depressive Disorder (MDD)/Clinical Depression
• Obsessive Compulsive Disorder (OCD)
• Other Therapeutic Applications

Chapter 7 Market Breakdown by Region

• Global Market for Neurostimulation Devices by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 8 Regulatory Structure

• Regulatory Framework
• U.S.
• European Union
• Japan

Chapter 9 Key Products and Technologies on the Market

• Recent Therapeutic Improvements and New Indications
• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation (SNS)
• Axonics
• Medtronic
• Vagus Nerve Stimulation
• Hypoglossal Nerve Stimulation
• Transcutaneous Electrical Nerve Stimulation
• Transcranial Magnetic Stimulation
• Other Types of Stimulation
• New Indications and Neurostimulation Therapies

Chapter 10 Emerging Technologies and Developments

• Emerging Technologies and Developments
• Closed-Loop Neurostimulation
• Non-Invasive Brain Stimulation Techniques
• High-Frequency Stimulation
• Magnetic Resonance-guided Focused Ultrasound
• Optogenetics
• Bioelectronic Medicine
• Wireless and Remote-Controlled Devices

Chapter 11 Recent M&A

• M&A in the Neurostimulation Technologies Industry

Chapter 12 Competitive Landscape

• Company Market Shares by Product Segment
• Spinal Cord Stimulation Devices
• Deep Brain Stimulation Devices
• Sacral Nerve Stimulation Devices
• Vagus Nerve Stimulation Devices
• Hypoglossal Nerve Stimulation Devices
• Transcranial Magnetic Stimulation Devices
• Transcutaneous Electrical Nerve Stimulation Devices
• Recent Industry Activities

Chapter 13 Company Profiles

• ABBOTT LABORATORIES
• ALEVA NEUROTHERAPEUTICS SA
• AVERY BIOMEDICAL DEVICES INC.
• AXONICS INC.
• BIOINDUCTION LTD.
• BIOVENTUS LLC
• BIOWAVE CORP.
• BOSTON SCIENTIFIC CORP.
• BRAINSWAY LTD.
• COCHLEAR AMERICAS
• CVRX INC.
• ELECTROCORE INC.
• INSPIRE MEDICAL SYSTEMS INC.
• INTEGER HOLDINGS CORP.
• LABORIE INC.
• LIVANOVA PLC
• MAG & MORE GMBH
• MAGSTIM INC.
• MEDTRONIC PLC
• NALU MEDICAL INC.
• NEUROMED CONSULTING INC.
• NEUROMETRIX INC.
• NEURONETICS INC.
• NEUROPACE INC.
• NEUROSIGMA INC.
• NEUROVALENS LTD.
• NEVRO CORP.
• NEXSTIM PLC
• NYXOAH SA
• SOTERIX MEDICAL INC.
• SYNAPSE BIOMEDICAL INC.
• XAVANT TECHNOLOGY (PTY) LTD.
• ZOLL MEDICAL CORP.

Chapter 14 Appendix: Acronyms